Inventor
TRIESELMANN THOMAS
DE21 patents
⚠️ This page may combine multiple inventors who share the name “TRIESELMANN THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
10 patentsUS7151114B2Dec 19, 2006
Use of substituted 2-phenylbenzimidazoles as medicaments
BOEHRINGER INGELHEIM INT17 citations84
US7977334B2Jul 12, 2011
Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT14 citations83
US11254688B2Feb 22, 2022
Benzyl-, (pyridin-3-yl)methyl -or (pyridin-4-yl)-methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitors
BOEHRINGER INGELHEIM INT1 citations62
USRE49446EMar 7, 2023
Oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors
BOEHRINGER INGELHEIM INT0 citations61
US11319310B2May 3, 2022
Heterocyclyl-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors
BOEHRINGER INGELHEIM INT1 citations61
US11136337B2Oct 5, 2021
Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors
BOEHRINGER INGELHEIM INT1 citations61
US10308667B2Jun 4, 2019
Oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors
BOEHRINGER INGELHEIM INT1 citations61
US11583532B2Feb 21, 2023
Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (GOAT) inhibitors
BOEHRINGER INGELHEIM INT0 citations51
US9994591B2Jun 12, 2018
Oxadiazolopyridine derivates for use as ghrelin O-acyl transferase (GOAT) inhibitors
BOEHRINGER INGELHEIM INT1 citations51
US7754756B2Jul 13, 2010
Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT0 citations38
CENTREXION THERAPEUTICS CORP
5 patentsUS11046706B2Jun 29, 2021
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP3 citations83
US10196402B2Feb 5, 2019
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP7 citations83
US9670222B2Jun 6, 2017
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP9 citations83
US11731981B2Aug 22, 2023
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP1 citations72
US12209094B2Jan 28, 2025
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP0 citations62
EBEL HEINER
3 patentsUS9067951B2Jun 30, 2015
Process and intermediates for the production of CCR2 antagonists
EBEL HEINER20 citations91
US8765949B2Jul 1, 2014
CCR2 receptor antagonists and uses thereof
EBEL HEINER9 citations83
US8835440B2Sep 16, 2014
Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
EBEL HEINER9 citations82